BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 33160003)

  • 1. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
    Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
    Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA Hsa_circ_0066755 as an Oncogene via sponging miR-651 and as a Promising Diagnostic Biomarker for Nasopharyngeal Carcinoma.
    Wang J; Kong J; Nie Z; Chen D; Qiang J; Gao W; Chen X
    Int J Med Sci; 2020; 17(11):1499-1507. PubMed ID: 32669952
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrative analysis of miRNAs-mRNAs reveals that miR-182 up-regulation contributes to proliferation and invasion of nasopharyngeal carcinoma by targeting PTEN.
    Shi Z; Wang R; Huang L; Chen X; Xu M; Zha D; Ma Y
    Aging (Albany NY); 2020 Jun; 12(12):11568-11578. PubMed ID: 32541092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition.
    Ke Z; Xie F; Zheng C; Chen D
    J Cell Physiol; 2019 Feb; 234(2):1699-1706. PubMed ID: 30070690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140/CCND1 and Hedgehog signaling pathway.
    Li L; Ma TT; Ma YH; Jiang YF
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10387-10399. PubMed ID: 31841193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3.
    Yin L; Chen J; Ma C; Pei S; Du M; Zhang Y; Feng Y; Yin R; Bian X; He X; Feng J
    Cell Death Dis; 2020 Jul; 11(7):562. PubMed ID: 32703944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1.
    Hong X; Liu N; Liang Y; He Q; Yang X; Lei Y; Zhang P; Zhao Y; He S; Wang Y; Li J; Li Q; Ma J; Li Y
    Mol Cancer; 2020 Feb; 19(1):33. PubMed ID: 32061262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
    Zhang Y; Zhang W
    Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B; Wang Y; Yin F
    Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3.
    Zheng ZQ; Li ZX; Zhou GQ; Lin L; Zhang LL; Lv JW; Huang XD; Liu RQ; Chen F; He XJ; Kou J; Zhang J; Wen X; Li YQ; Ma J; Liu N; Sun Y
    Cancer Res; 2019 Sep; 79(18):4612-4626. PubMed ID: 31331909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness.
    Lyu X; Fang W; Cai L; Zheng H; Ye Y; Zhang L; Li J; Peng H; Cho WC; Wang E; Marincola FM; Yao K; Cai H; Li J; Li X
    Mol Cancer; 2014 Mar; 13():51. PubMed ID: 24606633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA ITCH attenuates the progression of nasopharyngeal carcinoma by inducing PTEN upregulation via miR-214.
    Wang L; Sang J; Zhang Y; Gao L; Zhao D; Cao H
    J Gene Med; 2022 Jan; 24(1):e3391. PubMed ID: 34612550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
    BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of miR-1181 indicates a dismal prognosis for nasopharyngeal carcinoma and promoted cell proliferation and metastasis by modulating Wnt/β-catenin signaling.
    Hua X; Fan KC
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1077-1086. PubMed ID: 30779075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q; Hou S; Zhu X; Liu S
    World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
    Qian W; Ren Z; Lu X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.